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teria accounted for 67% of the differentially abundant organisms, followed by organisms of Firmicutes
(21%) and Actinobacteria (9%). At the species level, significant differences in abundance were seen for
75 species of which 58 species were significantly more abundant in CG patients. Notably, the FISH
analysis revealed that Bacteroidetes was the most prevalent phylum in NG. The multiplex cytokine assay
showed significant quantitative differences between the disease groups for eight analytes (GM–CSF, G–
CSF, IFN–฀, IL–4, IL–13, TNF–฀, MIG, and HGF). The G–CSF was found to be the most significantly
increased inflammatory protein marker in NG. The next-generation sequencing (NGS) data supported
the understanding of NG as a multi-microbial infection with distinct differences to CG in regard to the
microbial composition.
DOI: https://doi.org/10.3390/antibiotics10101197






The following work is licensed under a Creative Commons: Attribution 4.0 International (CC BY 4.0)
License.
Originally published at:
Gerhard, Nicolas; Thurnheer, Thomas; Kreutzer, Susanne; Gmür, Rudolf Dominik; Attin, Thomas;
Russo, Giancarlo; Karygianni, Lamprini (2021). Necrotizing Gingivitis: Microbial Diversity and Quan-





Necrotizing Gingivitis: Microbial Diversity and Quantification
of Protein Secretion in Necrotizing Gingivitis
Nicolas Gerhard 1, Thomas Thurnheer 1 , Susanne Kreutzer 2, Rudolf Dominik Gmür 1, Thomas Attin 1,
Giancarlo Russo 2,† and Lamprini Karygianni 1,*,†


Citation: Gerhard, N.; Thurnheer, T.;
Kreutzer, S.; Gmür, R.D.; Attin, T.;
Russo, G.; Karygianni, L. Necrotizing
Gingivitis: Microbial Diversity and
Quantification of Protein Secretion in
Necrotizing Gingivitis. Antibiotics
2021, 10, 1197. https://doi.org/
10.3390/antibiotics10101197
Academic Editor: Marc Maresca
Received: 14 August 2021
Accepted: 22 September 2021
Published: 1 October 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1 Clinic for Conservative and Preventive Dentistry, Center of Dental Medicine, University of Zurich,
Plattenstrasse 11, 8032 Zurich, Switzerland; nicigerhard@bluewin.ch (N.G.);
Thomas.Thurnheer@zzm.uzh.ch (T.T.); nickgmuer@bluewin.ch (R.D.G.); Thomas.Attin@zzm.uzh.ch (T.A.)
2 Functional Genomics Center Zurich, University of Zurich/ETH Zurich, 8057 Zurich, Switzerland;
susanne.kreutzer@fgcz.ethz.ch (S.K.); giancarlo.russo@uzh.ch (G.R.)
* Correspondence: lamprini.karygianni@zzm.uzh.ch; Tel.: +0041-44-634-3275
† These authors contribute equally to this work.
Abstract: Necrotizing gingivitis (NG) is a necrotizing periodontal disease that differs from chronic
gingivitis (CG). To date, both the microbiological causes and the involved host cytokine response of
NG still remain unclear. Here, we investigated corresponding interdental plaque and serum samples
from two groups of Chinese patients with CG (n = 21) or NG (n = 21). The microbiota were studied by
16S rRNA Illumina MiSeq sequencing of the microbial metagenome and by assessing quantitatively
the abundance of the phylum Bacteroidetes, the genus Prevotella and the species T. forsythia, P. endodon-
talis, and P. gingivalis using fluorescence in situ hybridization (FISH). With respect to the associated
host response, the levels of 30 inflammatory mediators were quantified by multiplex immunoassay
analysis. Differential microbial abundance analysis of the two disease groups revealed at the phylum
level that Proteobacteria accounted for 67% of the differentially abundant organisms, followed by
organisms of Firmicutes (21%) and Actinobacteria (9%). At the species level, significant differences
in abundance were seen for 75 species of which 58 species were significantly more abundant in CG
patients. Notably, the FISH analysis revealed that Bacteroidetes was the most prevalent phylum in NG.
The multiplex cytokine assay showed significant quantitative differences between the disease groups
for eight analytes (GM–CSF, G–CSF, IFN–α, IL–4, IL–13, TNF–α, MIG, and HGF). The G–CSF was
found to be the most significantly increased inflammatory protein marker in NG. The next-generation
sequencing (NGS) data supported the understanding of NG as a multi-microbial infection with
distinct differences to CG in regard to the microbial composition.
Keywords: fluorescence in situ hybridization (FISH); 16s rRNA; microbial metagenome; necrotizing
gingivitis; multiplex bead array assays (MBAA); cytokines
1. Introduction
Necrotizing gingivitis (NG) is a necrotizing periodontal disease with the characteristic
presentation of an acute, painful, and destructive process. The progression of the disease
can lead to necrotizing stomatitis and noma [1]. Characteristic clinical findings define
the diagnosis of NG: gingival pain; interdental necrosis, which appears as punched-out
gingival papilla; and gingival bleeding [2]. Further NG-related features are foetid breath,
pseudomembrane formation, and extraoral lymphadenopathy [3,4]. Originally described
as necrotizing ulcerative gingivitis, the term “ulcerative” was later eliminated, because
ulceration was considered to be secondary to necrosis [4].
Early findings regarding the NG-associated microbial composition of dental plaque
indicated the predominance of an endogenous, opportunistic fusiforme-spirochetal infec-
tion [5–9]. However, further studies have demonstrated that NG is a more complex and
variable mixed microbial infection, which does not necessarily include the predominance
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of a fusiforme-spirochetal complex as prescribed by Plaut and Vincent [2,10–12]. In the
meantime, Prevotella intermedia, Selenomonas spp., and Peptostreptococcus spp. are also con-
sidered to be highly NG-related bacterial species [3]. The NG-related gingival infection can
be modified by particular risk factors and interacts with a variety of host factors without
a predominant periodontal pathogen [13,14].
Depending on the population, the prevalence of NG varies broadly [15], although it
is generally rather low (<1%), especially in the industrialized societies of North America,
Europe, and Japan. Most likely, this is due to high health standards in these countries [13].
Interestingly, the true prevalence of NG has to be further investigated due to the fact that
relevant epidemiologic data were mainly obtained from non-representative population
groups (low socioeconomic class [16], HIV patients [17], military officers and soldiers [18],
and urban slum residents [13,19]) providing a probably skewed estimation.
In contrast to NG, chronic gingivitis (CG) is a widespread phenomenon, mainly in
children and adolescents [20]. Although the microbial etiology of CG is proven [21,22] and
similar to NG, the link to a specific individual or group of microorganisms has not been
proven [23,24].
According to the new classification scheme for periodontal diseases [3,25], CG is clas-
sified as a gingival disease, whereas NG constitutes a subgroup of periodontitis. Findings
have concluded that CG is a reversible state and a necessary prerequisite for periodontitis,
which is irreversible and more severe [26]. Therefore, patients with treated and stable
periodontitis are at higher risk for recurrent periodontitis than CG patients [26]. The clinical
symptoms of both diseases (CG, NG) vary broadly; the term CG describes the inflamed
state of the gingiva with >10% bleeding sites [27,28], and, upon clinical examination of
bleeding on probing (BOP %), probing depths > 3 mm [29]. Necrotizing diseases like
NG show three typical clinical features: pain, bleeding, and ulceration of the gingival
interdental papilla [3]. The extent, severity, and progression of CG and NG are mainly
dependent on host-related factors and systemic modifying factors [3,26].
Cytokine levels in NG samples have not been investigated so far. Although there have
been extensive studies on inflammation markers in CG and periodontitis in general [30],
which have confirmed elevated levels of specific cytokines depending on the clinical
severity of the disease, there are no literature reports describing the immunological status
of NG patients [31].
Due to the fact that only limited studies have investigated samples of NG-infected
patient groups so far, little is known about the microbial composition of dental plaque
and expression of inflammation markers in NG. To date, some bacterial species (Porphy-
romonas gingivalis, Actinomyces gerencseriae, Prevotella intermedia, Prevotella nigrescens [13])
have been detected using fluorescence in situ hybridization (FISH) or immunofluorescence
(IF), whereas the presence of other putatively pathogenic bacterial groups in NG (Tan-
nerella forsythia, Porphyromonas endodontalis, phylum Bacteroidetes, families Bacteroidaceae
and Prevotellaceae) has not yet been ascertained.
The objective of this study is to profile the immunologic as well as the microbial
landscapes associated with NG and CG and to detect differences that might help elucidate
NG- and CG-specific inflammatory and bacterial markers.
2. Material and Methods
The study protocol was approved by the Ethics Committee of the University of Zurich
(Basec Nr. Req-2019–01260). All assay protocols and data sampling were conducted in
accordance with relevant institutional and national guidelines and regulations. Thirty
inflammatory proteins were tested using an ELISA assay based on blood serum samples,
while marginal plaque was chosen to quantify six bacterial probes using FISH and fluo-
rescence microscopy and to extract DNA for 16S rRNA amplicon sequencing. The cohort
consists of 42 individuals, 21 NG, and 21 CG patients.
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2.1. Patients and Sample Collection
Patient selection, clinical examination, and collection of interdental marginal plaque
took place in 1998/1999 and were described previously [13,32]. In brief, upon giving
their written informed consent, 42 otherwise healthy Chinese patients with either NG
(n = 21; mean age of 36.9 ± 6.7 years) or CG (n = 21, 38.9 ± 6.3 years) formed our test
groups. All NG patients had multiple typical clinical signs for NG, such as interdental
necrosis, characterized by the loss of gingival papillae, pseudomembrane formation, fetid
odor, gingival pain, and ulceration [2], whereas CG patients displayed strong gingival
inflammation in the absence of any of the mentioned characteristic signs of NG. Marginal
supragingival plaque samples were collected from the buccal and/or oral surfaces of
the most disease-affected regions following a procedure previously described by the
authors [13,32–37]. Sample material from three infected sites was pooled in 1 mL reduced
transport fluid (RTF) containing 10% glycerol [38]. Plaque samples were split into aliquots
and stored in liquid nitrogen.
Peripheral blood samples were taken from the median cubital vein and the serum
was stored at –80 ◦C. Exclusion criteria during patient selection were (i) presence of any
form of severe systemic disease or diseases of the salivary glands, (ii) dentition with less
than 20 teeth, (iii) periodontal pockets with probing pocket depth 4 mm, and (iv) use of
antibiotics or local antimicrobial mouth rinses such as chlorhexidine (CHX) within the last
3 months.
2.2. DNA Extraction
The DNA from plaque samples (NG, CG) was isolated using the GenEluate bacterial
genomic DNA kit (Sigma-Aldrich, Saint Louis, MI, USA). The manufacturer’s recommen-
dations were followed except for slight modifications to the pretreatment steps required
for the lysis of Gram-positive bacteria: we extended lysis to 1 h using a mix of lysozyme
(2.115 × 106 U/mL), mutanolysin (250 U/mL), lysostaphin (200 U/mL) and achromopepti-
dase (600–1200 U/mL)) followed by treatment with proteinase K for 20 min. The extracted
DNA was eluted twice in 60 µl preheated elution buffer. The amount of isolated DNA
was determined using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific,
Waltham, MA, USA).
2.3. Amplification and Illumina MiSeq High-Throughput Sequencing
The variable regions V1–V3 of the 16S rRNA gene were amplified by PCR using
primers 27F 5- GAG TTT GAT CCT GGC TCA GAT TGA ACG C-3 and 534R 5-XXXXXXXX
ATT ACC GCG GCT GCT GG-3 [39]. PCR was carried out in a total volume of 50 µL
containing 1× NEBNext High-Fidelity PCR Mastermix (New England BioLabs), 1.25 µM of
each primer, and 5 µl of sample DNA. PCR steps included initial denaturation at 98 ◦C for
30 s, followed by 30 cycles consisting of denaturation at 98 ◦C for 10 s, annealing at 65 ◦C
for 30 s and extension at 72 ◦C for 30 s and a final extension step at 72 ◦C for 5 min. The
PCR products were purified with the NucleoSpin Gel and PCR Clean-up Kit (Macherey-
Nagel, Düren, Germany) according to the manufacturer’s protocol, using a 1:4 dilution of
the binding buffer NTI. The amount and the quality of the purified PCR amplicons were
analyzed by a Qubit fluorometer (Invitrogen, Waltham, MA, USA,) and by agarose gel
electrophoresis. For sequencing, the PCR amplicons were pooled in equimolar amounts.
The reverse primer contains inline barcodes for multiplexed sequencing. PCR prod-
ucts were pooled equimolar and Illumina sequencing adapters were attached using the
NEB Next Ultra II Library preparation Kit (NEB, Ipswich, MA, USA). The samples were
sequenced with 300 cycles paired-end on a MiSeq (600 cycles V3, Illumina, Inc, San Diego,
CA, USA) and demultiplexed according to the inline barcodes.
2.4. Analysis of the 16S rRNA Data
The fast files generated by the MiSeq were quality-filtered and adapters-trimmed using
Trimmomatic v0.39 [40]. Paired-reads that passed such preprocessing steps were joined
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using fastq-join [41] and then aligned to the Silva bacterial database using minimap2 [42].
Based on the alignments, genus-level abundances were obtained by aggregating all the
species with the same parent genus and compared with the FISH data. Krona plots were
generated using KronaTools [43].
2.5. Fluorescence In Situ Hybridization (FISH)
For semi-quantitative analysis of the phylum Bacteroidetes (CFB935), the families
Bacteroidaceae and Prevotellaceae (BAC303), and the genus Prevotella (PRV392), as well as
the bacterial species Porphyromonas gingivalis (L-Pgin1006–2), Porphyromonas endodontalis
(Pend740), and Tannerella forsythia (Tfor127), FISH was performed. In brief, the aliquots of
the pooled marginal plaque samples were thawed, homogenized by the standard vortexing–
sonication procedure for 10 s at 40–50 W on ice (Sonifier B-12; Branson, Danburg, CT, USA).
The CG and NG samples were diluted (1:50) in coating buffer (0.9% NaCl, 0.02% NaN3,
2.5 × 10–4% hexadecyltrimethylammonium bromide; CTAB) [34]. Ten microliters of these
suspensions were divided and fixed on 24-well epoxy-coated slides with a well diameter
of 4 mm (Cell-Line, Erie Scientific Company, Portsmouth, NH, USA) to be used for FISH as
previously described [34]. To include Gram-positive bacteria, additional permeabilization
was conducted as follows: 2 min exposure to 7 µL/well of lysozyme (70 U/µL), aspiration
of lysozyme droplet, brief dipping in nanopure water (H2O) followed by air-drying [44].
Blocking of unspecific binding included treatment with Denhardt’s solution (Sigma-Aldrich,
St. Louis, MO, USA; diluted (1:50) in 0.9% NaCl) in the presence of protectRNA RNase
inhibitor (1:500, Sigma-Aldrich Chemie GmbH, Buchs, Switzerland) in 0.9% NaCl and
incubation for 30 min at 37 ◦C [33]. Seven validated, labeled at the 5′- end with Cy3 or
carboxyfluorescein (FAM) (Microsynth, Balgach, Switzerland) and specific oligonucleotide
rRNA-directed probes were used. The sequences of the rRNA directed probes and bacterial
targets are listed in Table 1.
Table 1. Characteristics of 16S rRNA-directed oligonucleotide probes used for FISH; target organisms, rRNA sequences,
target site, and formamide concentration (F).
Probe 1 Target Sequence (5′–3) 2 5′ modification Target Site F (%) Source
BAC303
Most Bacteroidaceae and Prevotellaceae,
some Porphyromonadaceae
CCA ATG TGG GGG ACC TT Cy3 303–319 50 [45]
CFB935 Bacteroidetes (very broad) CCA CAT GTT CCT CCG CTT GT Cy3 935–954 50 [46]
EUB338
Many but not all bacteria/
most eubacteria
GCT GCC TCC CGT AGG AGT Carboxyfluorescein 338–355 40–50 [47]
L-Pgin1006–2 P. gingivalis GTT TTC ACC ATC MGT CAT C Cy3 1006–1024 45 [48]




Alloprevotella spp., Hallella spp.)
GCA CGC TAC TTG GCT GG Cy3 392–308 50 [50]
Tfor127 T. forsythia CTC TGT TGC GGG CAG GTT AC Cy3 127–146 40 [33]
1 Probes were labeled at the 5′-end with Cy3 (Cyanine dye 3) or carboxyfluorescein. The designations of probes containing locked-
nucleic-acid (LNA) substitutions start with L-. 2 Characters printed in bold indicate LNA substitutions. LNA incorporated DNA probes
(LNA/DNA probes) have been described to significantly improve fluorescence intensity in comparison to conventional DNA probes with
the same sequence.
The universal probe EUB338 was used as a reference [47]. The final probe concentra-
tions added to the individual wells were 5 ng µL−1 for Cy3 (Cyanine dye) and 20 ng µL−1
for FAM conjugates. Depending on the probe, 40–50% formamide as part of the hybridiza-
tion buffer was used. The backbone of the hybridization process is represented by the
previously described methods of Manz et al. [51] and Züger et al. [33], successively modi-
fied by Thurnheer et al. [52]. More precisely, the following alterations were made to the
workflow described in [33]: (i) increased duration of hybridization (240 min), (ii) general
DNA cell staining using 4′,6-diamidino-2-phenylindole (DAPI) incorporated in glycerol-
based mounting fluid (VECTASHIELD® Mounting Medium, Vector Laboratories Ltd.,
Peterborough, UK) was performed for all controls.
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2.6. Image Acquisition and Analysis
As described in earlier studies [44], upon FISH, the stained bacteria were visualized
using an Olympus BX60 epifluorescence microscope fitted with phase-contrast (Olympus
Optical AG, Volketswil, Switzerland), an HBO 103 W/2 mercury photo optic lamp for
excitation (OSRAM Lighting AG, Winterthur/Toess, Switzerland) and Olympus filter sets
U-MNIBA (FAM, FITC; excitation, 470–490 nm; emission, 515–550 nm) and U-MA41007
(Cy3; excitation, 530–560 nm; emission, 575–645 nm). Additionally, the 4′,6-diamidino-
2-phenylindole (DAPI) filter set U-MWU (excitation, 330–385 nm; emission > 420 nm)
was used for DNA staining. Exposure times for Cy3 and FAM were set at 800 ms and
2000 ms, respectively. Phase contrast-, colored-, and grayscale images of the FISH samples
were taken as 8-bit micrographs with an Olympus DP74 camera and the cellSens Entry
1.15 Imaging Software (Olympus Optical AG, Volketswil, Switzerland). At least 10 viewing
fields per well at 1000× magnification were chosen with respect to: (i) absence of artifacts
or aggregates, and (ii) presence of DAPI—stained bacteria. The grayscale images were
further analyzed using cellSens Dimension Desktop 1.15 Imaging Software (Olympus
Optical AG, Volketswil, Switzerland). For improved detection, automatic contouring of
every micrograph was conducted. The covering grades of the stained bacteria (in %)
were estimated by setting the areas of the Cy3 colored probes (target species) and FAM
colored probe (total eubacteria) in relation to each other. The density threshold of the
bacterial boundary was set manually for each image and stain. To be regarded as “true
signals”, the objects had to be: (i) positive after using phase-contrast imaging and DAPI
to avoid inclusion of possible false-positive signals, and (ii) positive for eubacteria. The
areas considered to be positive for the respective probe were cross-checked by both phase-
contrast- and colored images. The total area covered by the fluorescently labeled bacteria
was described as an absolute value in µm2. The stained area with positive fluorescence
signals for the EUB338 probe was taken as reference (100%) and the covering grade of the
other probes was finally measured as a percentage (%) of the EUB338—positive areas.
2.7. Determination of Cytokines, Chemokines, and Growth Factors
The serum samples of the CG and NG patients were thawed and intensely vortexed
for 30 s. Subsequent centrifugation at 4 ◦C at 21,000× g for 5 min in 1.5 mL Protein LoBind
Tubes (Eppendorf AG, Hamburg, Germany) pelleted any insoluble material [53]. The final
sample of 50 µL as duplicates (twice for a total of 100 µL) of clear supernatant was removed
and used according to the instructions of the Human Cytokine Magnetic 30 Plex Panel
(Novex, ThermoFisher Scientific, Waltham, MA, USA) [54]. This panel quantifies cytokines,
chemokines, and growth factors in the collected medium [54]. Levels of the analytes in
pg/ml were detected by multiplex bead array assays (MBAA) and read by Luminex® 200
(Bio-Rad Laboratories Inc., Hercules, CA, USA). Analysis of the data was conducted by
polynomial interpolation in Microsoft Excel for further statistical processing.
2.8. Statistical Analysis
To check for statistical differences between the two clinical groups with respect to
the quantitative protein assay and FISH staining, a Mann–Whitney test was employed.
We used Bonferroni (in the case of the FISH assay) or Benjamini–Hochberg correction
(in the case of the ELISA assay, due to the presence of protein families) to account for
multiple testing. In order to compare differential abundances between the groups in the
16S rRNA-based NGS data, edgeR [55] was used.
3. Results
3.1. Analysis of the Bacterial Communities in the Two Cohorts: FISH
Box plots in Figure 1 depict the relative abundance of the six hybridized oligonu-
cleotide probes in the FISH—treated dental plaque samples from subjects with CG and NG.
The corresponding targets of the probes can be seen in Supplementary Table S1; CFB935 is
considered as the “Bacteroidetes” probe.
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Figure 1. Box plots showing the abundance of six taxa in relation to the total amount of bacteria in samples from patients with
chronic (n = 21) or necrotizing gingivitis (n = 21). Data are shown for the phylum Bacteroidetes, the families Bacteroidaceae and
Prevotellaceae, the genus Prevotella and the species P. gingivalis, P. endodontalis und T. forsythia. Note that y-axis scales are different for
each taxon. 16S rRNA probes used to detect the different taxa are described in Supplementary Table S1. p-values were calculated
with the Bonferroni-corrected Mann–Whitney test; p < 0.0001 (****), p < 0.01 (**). CG, chronic gingivitis; NG, necrotizing gingivitis.
CFB935; BAC303; PRV392; L–P GIN 1006–2; Pend740; Tfor127 are probes with different targets (see Table 1).
Probe CFB935 represents, on average, the probe that, among those tested, captured
the largest amount of microorganisms in both NG and CG biofilms. However, at 30.6%
and 6.7%, there is a strong significant difference (p < 0.0001) between the two groups; in
particular, the probe CFB935 was significantly more abundant in NG. Interestingly, among
CG patients we identified one outlier, showing a high CFB935 abundance (24.7%), while
in the NG group, two patients presented a lower proportion of cells stained by this probe
(17.5% and 14.6%).
The other probe which shows a statistical difference in its abundance between the two
groups (p < 0.01) is BAC303. Its fraction is much lower than CFB935, with mean values in
the CG and NG groups of 1.91% and 0.70%, respectively.
No significant differences were detected between CG and NG groups with respect to
the cell content stained with the other four probes (Supplementary Table S2).
Supplementary Figure S1 contains representative fluorescence microscopy (FM) im-
ages of the same samples generated with FISH following hybridization with the aforemen-
tioned probes.
Fluorescence microscopy (FM) panels illustrating the presence of specific phyla, gen-
era, and bacterial species related to necrotizing gingivitis. Images were generated with
FISH and FM following hybridization with the following oligonucleotide probes: broad-
spectrum CFB935 staining cells of the phylum Bacteroidetes with diverse morphology (A);
BAC303 staining differently sized aggregates of Bacteroides spp., Prevotella spp., and Por-
phyromonas spp. (B); PRV392 staining rod-shaped cells of Prevotella spp. (C); Pend740 and
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L-Pgin1006-2 staining small, round cells of P. endodontalis (D) and P. gingivalis (E), respec-
tively. The bacterial targets are zoomed and highlighted on white-framed sub-images in
panels A and C.
3.2. Analysis of the Bacterial Communities in the Two Cohorts: 16S rRNA NGS Comparison with
FISH Data
In addition to using FISH probes to capture predefined organisms, we also amplified
and sequenced the 16S rRNA V1-V3 regions in order to screen the microbial community
of the cohorts. To gauge the robustness of the NGS profiling, we first compared it with
the FISH data. In Figure 2, we show the coefficients of correlation between the relative
abundances calculated based on the NGS analysis and those based on the FISH staining.
Of course, this is only possible for the genera (or set of genera) included in the FISH probes.
Figure 2. Correlation between the FISH-based and NGS-based relative abundances of the selected
microbial species. The plotted value is the Pearson coefficient between the species quantities in each
sample. Samples with R2 < 0.2 are labeled.
For the majority of the samples, the level of correlations is above 0.5 and can be
considered moderately strong. The samples labeled in Figure 2 have a correlation coefficient
below 0.2 (very weak) and therefore we decided to remove them from further analysis
of the NGS data. Additionally, samples 47A_NG, 33A_NG, and 5A_CG have also been
removed from downstream analyses involving NGS-based data, because more than 50% of
the species identified in the pool were not observed (zero counts).
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3.3. Further Profiling the Microbial Communities
A differential abundance analysis revealed 75 species as significantly different be-
tween the two groups, whose taxonomic distribution is depicted as Krona charts in Figure 3.
Specifically, 58 species were significantly more abundant among CG patients, and the ma-
jority of such difference was driven by the phylum Proteobacteria, which accounted for 67%
of the differentially abundant organisms, followed by Firmicutes (21%) and Actinobacteria
(9%). Almost all of the Proteobacteria (90%) belonged to the class Gammaproteobacteria, which
also accounted for two-thirds (60%) of the total number of differentially abundant species.
Pseudomonas and Lysobacter are the most abundant genera (20% of Gammaproteobacteria, 12%
of the total number of differentially abundant species), while almost half of the Firmicutes and
10% of the total number of differentially abundant species were Streptococcus spp.
Figure 3. Krona plots of the taxonomies of the organisms which resulted in differentially abundant
in the NGS analysis between the CG and NG groups. (A) Species overabundant in the CG group.
(B) Species overabundant in the NG group. The full taxonomy of each species was reconstructed
using the R package myTAI with the itis and NCBI databases.
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Among the 17 species which were more abundant in the NG patients, 10 (59%) were
Proteobacteria, of which 8 belonged to the Campylobacter family. The second most abundant
phylum was Bacteroidetes (6 species, 35%); of those, 4 belonged to the Prevotellaceae family
and one to the Porphyromonadaceae. This further confirmed the results obtained by FISH
analysis with respect to the probe CFB935.
A snapshot of the baseline microbial environment in the two groups is shown in
Figure 4. Altogether, at the phylum level, the two groups had a very similar profile, with
Proteobacteria being the most dominant phylum and representing ca. 90% of the population.
However, as just discussed and shown in Figure 3, the deteriorating transition to NG was
driven by a relative depletion of Firmicutes and a spike in Bacteroidetes to ca. 35%.
Figure 4. Relative prevalence of the ten most abundant species among the entire microbiome (“Full
list”), the subset of species overabundant in the CG patients, and the subset of species overabundant
in the NG.
3.4. Analysis of the Expression of the Protein Markers
On average, the thirty proteins tested using the 30-plex MBAA displayed pretty
similar expression levels between the groups (Supplementary Figure S2), including the
very high concentration levels of RANTES (ca. 20 times the sample-wise mean in both
NG and CG cohorts) and IL-8 (4 and 7 times the sample-wise mean in the NG and CG
cohorts, respectively).
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The heatmap shows the concentration (in pg/ml) of a total of 30 cytokines, chemokines
and growth factors among chronic gingivitis and necrotizing gingivitis patients. The rows
are ordered by mean concentration value stratified according to the color bar on the right.
Out of these 30 proteins, six (G-CSF, GM-CSF, HGF, IL-13, MIG, and TFN-α) were
differentially abundant between the two groups (Figure 5). In all cases, the significantly
higher protein expression was found in the NG cohort, suggesting a stronger inflammatory
response driven by NG. However, it can be seen how in three cases (GM-CSF, IL-13, and
MIG) the difference was driven by a handful of outliers over a rather low background
signal, and therefore conclusions around these proteins should be more cautious. Of note,
the cytokine G-CSF was the inflammatory marker with the highest level of up-regulation
in necrotizing gingivitis, with a Benjamini–Hochberg adjusted p-value (p = 0.003) one order
of magnitude more significant than the other five significantly different markers (Figure 5).
Figure 5. Box plots showing the concentration of the six proteins which are significantly differentially
expressed between the NG and CG group. P-values were calculated using the Benjamini-Hochberg-
corrected Mann-Whitney test.
With multiple sources of molecular information available, we also tried to investigate
whether an interplay between the proteins and the microbial species associated with the
diseases occurs. The three datasets (FISH, ELISA, and NGS) were integrated using the R
package mixOmics with the main goal to identify co-signatures associated with multiple
data sources (also called blocks in the package). As in each block, the main discriminative
component was identified, and a correlation between such components was calculated
for each pair of datasets. In this respect, the correlations were moderately strong for all
three datasets, with the FISH and NGS blocks showing the highest correlation (R = 0.69).
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The corresponding discriminating effect of the individual blocks is shown in Figure 6A:
one notices how robust discrimination between the groups was in all three blocks, which
showed little to no overlap along the x-axis. However, the second component correlated
well only in the NGS and ELISA datasets (R =0.59, Supplementary Table S3), suggesting
a potential co-signature from these blocks.
Figure 6. Cont.
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Figure 6. Integration of the three sources of data. (A) Individual principal component plots for the three blocks. Plot generated
using the function plotIndiv from the package mixOmics. (B) Correlation circle plot: the further away from the origin, the
higher the discriminative power of the features. Features clustering together represent potential co-signature from multiple
data sources. Plot generated using the function plotVar from the package mixOmics. (C) Heatmap highlighting co-segregation
of different data sources and the discriminative potential of the resulting clusters. The key color scales are based on Z-scores
and scaled based on the row mean. Plot generated using the function cimDiablo from the package mixOmics.
Abundance and statistical analysis of the ELISA-based quantification for the 30 se-
lected protein inflammatory markers.
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Additional evidence that the NGS and ELISA blocks showed an additional predictive
power and an interplay between some of their features is shown in Figure 6B: the main
component, along the x-axis, was polarized by a cluster of mostly NGS features, whereas
the second main component, along the y-axis, was polarized by another NGS-dominated
cluster also including some ELISA features. Finally, we asked ourselves which features are
actually driving this behavior, and the results are shown in Figure 6C. The dendrogram
clearly splits the features into two main clusters, each of which branches into two further
groups. For the bottom cluster, the top branch, starting with S. hongkongensins and ending
with D. magneticus does not show any particular trend, while the bottom branch displays
an overall enrichment in the CG group and comprises several Streptococcus spp. whose
spike in the CG group is already shown in Figure 4. The top cluster is instead picking up
the up-regulation in the NG group; the top branch includes the proteins (including two of
the three—G-CSF, HGF—which were found differentially abundant by means of the ELISA
assay). The bottom branch includes the NGS-identified species, clearly showing the many
Campylobacter spp. which are overabundant in the NG group and essentially replicating
the results observed by analyzing the NGS dataset alone in the classical way (Figure 3B).
Such sub-clustering of protein and microbial features is another way to depict the interplay
seen in the y-axis cluster in Figure 6B.
4. Discussion
The present study confirmed the assumption that NG is an opportunistic, mixed
microbial infection. The FISH-stained microscopic images demonstrated the increased
occurrence of the phylum Bacteroidetes, while the genera Porphyromonas spp. and Tanerella
spp. showed an increase among NG patients (CFB935 probe). Several studies from our own
group have so far focused on NG [13,32–37,56], revealing the prevalence of Actinomyces
gerencseriae, Campylobacter rectus, Fusobacterium nucleatum/Fusobacterium periodonticum,
Porphyromonas gingivalis, Prevotella intermedia/Prevotella nigrescens, and Tannerella forsythia
after FISH-staining and subsequent FM [13,33,34,44,52,57]. The protein quantification
revealed an increased expression of inflammatory markers in NG contrary to CG.
Plaque harboring highly diverse bacteria and the presence of the above-mentioned bac-
terial species has been proved by other 16S rRNA studies [58]. The 16S rRNA gene-based
analysis is an effective method for the characterization of the oral microbiota [59]. The sig-
nificantly higher prevalence of CFB935-stained oral genera in NG compared to CG patients
confirmed the understanding of NG as a mixed microbial infection rather than a disease
with abundant fusiform-spirochete bacterial flora [60]. The probe CFB935 described as
Cytophaga–Flexibacter–Bacteroides assemblage contains among other species the putative
periodontal pathogens P. gingivalis, P. intermedia, P. endodontalis, and T. forsythia [13,34,49,61,62].
In our study, about 30% of the bacteria stained with the EUB338 probe consisted of the
aforementioned bacteria. The EUB338 probe detects most of the domain Bacteria except for
target organisms of the phyla Planctomycetales and Verrucomicrobia [63]. These specific
bacterial species may display an “inflammophilic” profile and can support the occurrence
and progression of NG in the presence of a weak immune response [62]. However, the
high incidence of Bacteroidetes in NG in contrast to CG may be attributed to the fact that the
bacterial genome sequence data contain only part of the sequences of oral bacteria.
The high prevalence of P. gingivalis among NG patients (0.7%) versus CG patients
(0.1%) was highlighted by Gmür et al. [13]. The results of the present study, which showed
no significant differences in P. gingivalis between NG (0.2%) and CG (0.2%) samples, suggest
that further studies on single bacterial species will be required in order to detect differences
in the bacterial composition between NG and CG patients. A possible explanation for the
non-significance could be the expression of different subtypes of fimA genotypes [64,65].
Additionally, it is possible that aggregates of diverse Porphyromonas are not appropriately
represented in the image acquisition.
To have an overview of the microbial populations in the oral cavities of the patients, we
amplified the 16S rRNA region from the DNA and performed high-throughput sequencing.
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On the one hand, the previously reported roles of individual species in the progression
of NG was confirmed and expanded to close relatives, as in the case of Campylobacter and
Prevotella spp. Both genera are known to be associated with periodontal disease [66] and
our findings might point to their stronger involvement in the more advanced forms of
pathologies such as NG. On the other hand, Lysobacter spp. and Streptococcus spp. were
significantly upregulated in the CG samples. As Lysobacter spp. and Streptococcus spp.
populate the oral cavity in normal conditions, and since gingivitis represents an early
stage, less inflammatory form of periodontitis, it is likely that what we are observing is
a displacement of some of these more common, generally innocuous species by their more
pathogenic and inflammatory counterparts.
The immune response of a patient is modulated by proteins such as chemokines
(chemotactic cytokines), cytokines, and growth factors [67–70], whose complex interaction
leads to a vicious cycle with cumulation in tissue destruction and disease progression.
The MBAA revealed that NG elicited the strong response of three serum cytokines (G-
CSF, TNF-α, and HGF) and an additional, albeit less conclusive, upregulation of further
three cytokines (GM-CSF, IL-13, and MIG).
The NG is a severe chronic inflammation characterized by an elevated granulocyte ac-
tivity and thus, an increase in the number of blood neutrophils. Colony-stimulating factors
(CSF) constitute a group of four different cytokines (granulocyte-macrophage colony-
stimulating factor (GM-CSF), macrophage colony-stimulating factor (M-CSF), granulocyte
colony-stimulating factor (G-CSF) and multi-CSF (interleukin [IL-3]) [71]. They are pro-
duced by activated leukocytes and stimulate the proliferation, differentiation, maturation,
and survival of granulocytes and macrophages. These cytokines play a myriad of roles
in inflammation as pro-inflammatory cytokines [72–74]. The cytokine G-CSF regulates
granulopoiesis, serves as a key mediator of the stress granulopoiesis response [75], and
also affects neutrophil phenotype and function [76]. The G-CSF concentration increases
in the serum at inflammatory sites [77,78]. Beneath its function as a CSF [75], GM-CSF
affects and modulates more myeloid cell types, especially macrophages, granulocytes
and eosinophils [79]. Expression of GM-CSF is normal under homeostatic conditions but
increased under inflammatory conditions [80] as confirmed by the findings of this study.
Hamilton et al. [72] described a pro-inflammatory ‘CSF network’ of mutual depen-
dence between CSF activity and the activity of monocyte- or macrophage-derived pro-
inflammatory cytokines (such as IL-1 and TNF) [81].
In oral epithelial cells, IL-1b and TNF-alpha induce COX-2 leading to increased
prostaglandin E2 production in HGFs [82,83]. In their study, Noguchi et al. [84] observed
that high prostaglandin concentrations resulted in increased cytokine secretion, mainly
due to positive feedback loops which contribute to the exacerbation of inflammation. In
another report, De Oliveira et al. [85] stated that TNF-alpha plays a crucial role in the innate
response against the periodontopathogenic bacteria. Interestingly, high levels of TNF-a,
which activates pathways that culminate in the destruction of periodontal connective tissue
and alveolar bone resorption [86,87], were detected in diseased sites of individuals with
severe periodontitis [88].
The hepatocyte growth factor (HGF) is produced by fibroblasts from human gingiva
by IL-1, TNF-alpha, and by prostaglandin E2 [89,90]. Other than that, it can be induced in
culture by fimbriae of P. gingivalis [91] as well as P. intermedia [92]. This cytokine promotes
the progression of periodontitis, by stimulating intense growth of epithelial cells and
preventing regeneration of connective tissue attachments [93]. Increased levels of HGF
in NG patients underline the pathogenic effects of HGF as a clinical parameter of disease
progression [94].
IL-13 is a Th2 anti-inflammatory cytokine that regulates the collagen homeostasis
by up-regulation of TGF-β [95] and down-regulation of collagen-destroying MMP-1 pro-
duction [96]. Elevated levels of IL-13 have been detected in T-cells of severe periodontitis
patients [97]. More recent research attributes IL-13 a pivotal role in the regulation of
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type 2 cytokine-mediated immune responses as a key inducer of many pathological pro-
cesses [98].
The chemokine MIG (monokine induced by interferon (IFN)-γ) is stimulated by
increasing production of IFN-γ and TNF-a from recruited Th1 lymphocytes, leading to
a positive amplification feedback loop in inflammatory lesions [99,100]. MIG is considered
as a marker of the host immune response due to its T-cell chemoattractant effect, has
a central function in the recruitment of inflammatory cells [99,101], and is up-regulated
by RANKL in osteoclast precursor cells [102]. The findings in our study are in agreement
with past studies, which showed increased serum levels of MIG in different organs in
autoimmune diseases [103].
The integration of the different data sources ties together the observations discussed
so far at the microbial and protein levels. All significant inflammatory activities identified
by the ELISA assay represent, together with the species highly abundant in the NG samples,
a co-signature for the NG. In particular, a broader inflammatory response involving, to-
gether with the significantly overexpressed HGF and G-CSF clearly indicates that the shift
in the microbial composition of the plaque associated with the transition from the milder
CG to the more serious NG plays a relevant role, particularly via the Campylobacter spp., in
the evolution of the most severe symptoms of the disease.
5. Conclusions
To the best of our knowledge, this study is the first attempt to detect inflammation
markers in NG patients and to integrate the microbial and inflammatory landscapes of
the disease. This allowed a better understanding of the complexity of the necrotizing
disease in the context of cytokine production and pointed to the potential role of specific
microorganisms in the orchestration of such inflammatory response.
In conclusion, this study indicates that NG is an opportunistic, mixed microbial infec-
tion with elevated cytokine levels in the serum. Our results suggest an association between
specific microbial sub-ecosystems and elevated pro-inflammatory proteins in the blood
serum. It is hard to gauge to what extent this represents a causal relationship. However,
our findings further reinforce the theory of dysbiosis, i.e., that neither a specific periodontal
pathogen nor cytokine is responsible for the disease, but the synergistic interaction of the
microbial composition in combination with a diminished host response [62].
Patients undergoing preimplant surgical procedures are prone to contamination which
can lead to perimplantitis [104,105]. Minimally invasive tools, such as digital dentistry
can help to avoid microbial infections. Other approaches involve the use of implants with
reduced bacterial leakage and emerging stem cell therapy [106,107].
Additional approaches, such as proteomic analysis, might help to further elucidate
the molecular mechanisms underpinning the deteriorating pattern of periodontal diseases.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/antibiotics10101197/s1, Figure S1: Fluorescence microscopy (FM) panels illustrating the
presence of specific phyla, genera and bacterial species related with necrotizing gingivitis. Images
were generated with FISH and FM following hybridization with the following oligonucleotide
probes: broad - spectrum CFB935 staining cells of the phylum Bacteroidetes with diverse mor-
phology (A); BAC303 staining differently sized aggregates of Bacteroides spp., Prevotella spp., and
Porphyromonas spp. (B); PRV392 staining rod - shaped cells of Prevotella spp. (C); Pend740 and
L-Pgin1006-2 staining small, round cells of P. endodontalis (D) and P. gingivalis (E), respectively. The
bacterial targets are zoomed and highlighted on white - framed subimages in panels A and C.
Figure S2: Heatmap showing the concentration (in pg/mL) of a total of 30 cytokines, chemokines and
growth factors among chronic gingivitis and necrotizing gingivitis patients. The rows are ordered by
mean concentration value stratified according to the color bar on the right. Table S1: Characteristics of
16S rRNA-directed oligonucleotide probes used for FISH; target organisms, rRNA sequences, target
site and formamide concentration (F).Table S2: Abundance and statistical analysis of the FISH-based
quantification for the six selected bacterial probes. Table S3: Abundance and statistical analysis of the
ELISA-based quantification for the thirty selected protein inflammatory markers.
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